Information about RADICAVA

 

The FDA has approved Radicava™, the first new treatment specifically for ALS in 22 years. The drug was approved by the FDA less than a year after Mitsubishi Tanabe Pharma Corporation submitted a New Drug Application. The only other approved treatment specifically for ALS, riluzole, was approved in 1995. Please click the links on the right to find more information on Radicava and check back often for updates.

Past Webinars

May 9th Webinar:
Download Slides / Watch a Recording

May 12th Webinar:
Watch a Recording

The FDA has approved Radicava™, the first new treatment specifically for ALS in 22 years. The drug was approved by the FDA less than a year after Mitsubishi Tanabe Pharma Corporation submitted a New Drug Application. The only other approved treatment specifically for ALS, riluzole, was approved in 1995. Please click the links below to find more information on Radicava and check back often for updates.

Past Webinars

May 9th Webinar:
Download Slides / Watch a Recording

May 12th Webinar:
Watch a Recording

Press Release


FAQ


Connect With Us

When you sign up with our chapter, you’ll learn how you can help secure more funding for ALS research, expand care and resources for people living with this disease and their families, and advance legislative priorities that are important to the entire ALS community.

Sign Up Today